Mobidiag: Finnish biotech Mobidiag sold to US firm Hologic for $795 million

U.S. women health firm Hologic said has signed a definitive agreement to acquire privately-held Mobidiag Oy in a deal that values the Finnish-French developer of innovative molecular diagnostic tests and instrumentation at $795 million. The deal value includes a cash payment of approximately $714 million (€600 million) for Mobidiag's equity and net debt of approximately [...] The post Finnish biotech Mobidiag sold to US firm Hologic for $795 million appeared first on ArcticStartup.